Fibrinogen Elevation and Cardiovascular Risk

Understanding Fibrinogen Elevation

Fibrinogen increases during any inflammatory process as an acute phase protein, similar to C-reactive protein, and a level of 4.48 g/L indicates an active inflammatory state 3, 4, 1
The physiological range in non-pregnant adults is 2.0-4.0 g/L, and elevations occur with infection, inflammation, malignancy, tissue injury, and cardiovascular disease 3, 5, 2
This mild elevation does NOT indicate a bleeding disorder—critically low fibrinogen (<1.0-1.5 g/L) is what predicts bleeding risk, not elevation 1, 5

In the FRISC trial, elevated fibrinogen was associated with both short-term and long-term risk of death and subsequent MI 6, 2

A level of 4.48 g/L represents mild elevation in the context of residual inflammatory risk, suggesting an ongoing inflammatory process that warrants investigation 1, 2
The elevation itself indicates increased thrombotic risk, not bleeding risk—you should be concerned about clotting complications if other risk factors are present 1

Measure high-sensitivity C-reactive protein (hs-CRP) to assess the degree of systemic inflammation, as CRP and fibrinogen typically rise together and provide complementary prognostic information 6, 2
Complete blood count with differential to evaluate for infection, inflammatory conditions, or malignancy 1
Assess for underlying inflammatory conditions: cardiovascular disease, active infection, autoimmune disease, malignancy, or tissue injury 3, 4, 2
Optimize standard cardiovascular risk factors rather than targeting fibrinogen specifically—this means aggressive management of hypertension, dyslipidemia, diabetes, and smoking cessation 2
Consider thromboprophylaxis based on overall clinical context and standard risk assessment tools (not based on fibrinogen level alone), recognizing that elevated fibrinogen increases thrombotic risk 1, 2

Repeat fibrinogen measurement after treating any identified underlying inflammatory condition to assess whether the elevation resolves 1
Serial measurements are more informative than a single value—persistent elevation suggests chronic inflammation requiring further investigation 1, 5

The Clauss method (standard laboratory test) can overestimate fibrinogen in the presence of artificial colloids like hydroxyethyl starch, though this is unlikely in your outpatient scenario 5, 2
Different laboratories may use slightly different reference ranges (1.8-3.5 g/L vs 2.0-4.0 g/L), so your 4.48 g/L is consistently elevated regardless 3, 5
In pregnancy, fibrinogen levels of 3.7-6.2 g/L are normal in the third trimester, so your level would be unremarkable if pregnant 1
In acute coronary syndromes, the combination of elevated fibrinogen and elevated CRP provides additive prognostic information and identifies patients who may benefit most from intensive management 6
Do NOT empirically treat with fresh frozen plasma or fibrinogen concentrate—these are reserved for active bleeding with low fibrinogen (<1.5 g/L) 1, 2
Do NOT interpret this as a contraindication to procedures—elevated fibrinogen does not increase bleeding risk during invasive procedures 1